{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:32:27Z","timestamp":1792096347832,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:00:00Z","timestamp":1232409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:00:00Z","timestamp":1232409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The urinary level of the type II collagen degradation marker CTX-II is increased in postmenopausal women and in ovariectomised rats, suggesting that oestrogen deprivation induces cartilage breakdown. Here we investigate whether this response to oestrogen is also true for other type II collagen turnover markers known to be affected in osteoarthritis, and whether it relates to its presence in specific areas of cartilage tissue.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The type II collagen degradation markers CTX-II and Helix-II were measured in the body fluids of premenopausal and postmenopausal women and in those of ovariectomised rats receiving oestrogen or not. Levels of PIIANP, a marker of type II collagen synthesis, were also measured in rats. Rat knee cartilage was analysed for immunoreactivity of CTX-II and PIIANP and for type II collagen expression.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>As expected, urinary levels of CTX-II are significantly increased in postmenopausal women and also in oestrogen-deprived rats, although only transiently. However, in neither case were these elevations paralleled by a significant increase of Helix-II levels and PIIANP levels did not change at any time. CTX-II immunoreactivity and collagen expression were detected in different cartilage areas. The upper zone is the area where CTX-II immunoreactivity and collagen expression best reflected the differences in urinary levels of CTX-II measured in response to oestrogen. However, correlations between urinary levels of CTX-II and tissue immunostainings in individual rats were not statistically significant.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>We found only a small effect of oestrogen deprivation on cartilage. It was detected by CTX-II, but not by other type II collagen turnover markers typically affected in osteoarthritis.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2596","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T19:13:27Z","timestamp":1233774807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover"],"prefix":"10.1186","volume":"11","author":[{"given":"Anne-Christine","family":"Bay-Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine CB","family":"Tabassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene V","family":"Sondergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Dagnaes-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Garnero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustapha","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Delaiss\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,20]]},"reference":[{"key":"2444_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1067\/mgn.2001.116375","volume":"22","author":"PC Birchfield","year":"2001","unstructured":"Birchfield PC: Osteoarthritis overview. Geriatric Nursing. 2001, 22: 124-131.","journal-title":"Geriatric Nursing"},{"key":"2444_CR2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1302\/0301-620X.58B1.131804","volume":"58","author":"CA McDevitt","year":"1976","unstructured":"McDevitt CA, Muir H: Biochemical changes in the cartilage of the knee in experimental and natural osteoarthritis in the dog. J Bone Joint Surg Br. 1976, 58: 94-101.","journal-title":"J Bone Joint Surg Br"},{"key":"2444_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1042\/bj1880823","volume":"188","author":"DR Eyre","year":"1980","unstructured":"Eyre DR, McDevitt CA, Billingham MEJ, Muir H: Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J. 1980, 188: 823-837.","journal-title":"Biochem J"},{"key":"2444_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF02899701","volume":"62","author":"T Aigner","year":"1992","unstructured":"Aigner T, Stoss H, Weseloh G, Zeiler G, Mark von der K: Activation of collagen type II expression in osteroarthritic and rheumatoid cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992, 62: 337-345.","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"2444_CR5","doi-asserted-by":"publisher","first-page":"39027","DOI":"10.1074\/jbc.M006700200","volume":"275","author":"N Verzijl","year":"2000","unstructured":"Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, Bijlsma JWJ, Lafeber FPJG, Baynes JW, TeKoppele JM: Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000, 275: 39027-39031.","journal-title":"J Biol Chem"},{"key":"2444_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.joca.2008.01.002","volume":"16","author":"YH Sniekers","year":"2008","unstructured":"Sniekers YH, Weinans H, Bierma-Zeinstra SM, van Leeuwen JP, van Osch GJ: Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment \u2013 a systematic approach. Osteoarthritis Cartilage. 2008, 16: 533-541.","journal-title":"Osteoarthritis Cartilage"},{"key":"2444_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00003086-198612000-00010","volume":"213","author":"IA Rosner","year":"1986","unstructured":"Rosner IA, Goldberg VM, Moskowitz RW: Estrogens and osteoarthritis. Clin Orthop Relat Res. 1986, 213: 77-83.","journal-title":"Clin Orthop Relat Res"},{"key":"2444_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/ard.55.9.673","volume":"55","author":"MC Nevitt","year":"1996","unstructured":"Nevitt MC, Felson DT: Sex hormones and the risk of osteoarthritis in women: epidemiological evidence. Ann Rheum Dis. 1996, 55: 673-676.","journal-title":"Ann Rheum Dis"},{"key":"2444_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00002281-199805000-00019","volume":"10","author":"DT Felson","year":"1998","unstructured":"Felson DT, Nevitt MC: The effects of estrogen on osteoarthritis. Curr Opin Rheumatol. 1998, 10: 269-272.","journal-title":"Curr Opin Rheumatol"},{"key":"2444_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0378-5122(00)00118-3","volume":"35","author":"AE Wluka","year":"2000","unstructured":"Wluka AE, Cicuttini FM, Spector TD: Menopause, oestrogens and arthritis. Maturitas. 2000, 35: 183-199.","journal-title":"Maturitas"},{"key":"2444_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/joca.1999.0260","volume":"7","author":"T Ushiyama","year":"1999","unstructured":"Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S: Expression of genes for estrogen receptors [alpha] and [beta] in human articular chondrocytes*1. Osteoarthr Cartil. 1999, 7: 560-566.","journal-title":"Osteoarthr Cartil"},{"key":"2444_CR12","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/1529-0131(200009)43:9<2081::AID-ANR20>3.0.CO;2-I","volume":"43","author":"RS Richmond","year":"2000","unstructured":"Richmond RS, Carlson CS, Register TC, Shanker G, Loeser RF: Functional estrogen receptors in adult articular cartilage. Estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2. Arthritis Rheum. 2000, 43: 2081-2090.","journal-title":"Arthritis Rheum"},{"key":"2444_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.joca.2003.08.002","volume":"12","author":"KD Ham","year":"2004","unstructured":"Ham KD, Oegema TR, Loeser RF, Carlson CS: Effects of long-term estrogen replacement therapy on articular cartilage IGFBP-2, IGFBP-3, collagen and proteoglycan levels in ovariectomized cynomolgus monkeys. Osteoarthr Cartil. 2004, 12: 160-168.","journal-title":"Osteoarthr Cartil"},{"key":"2444_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1136\/ard.60.6.619","volume":"60","author":"P Garnero","year":"2001","unstructured":"Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E: Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001, 60: 619-626.","journal-title":"Ann Rheum Dis"},{"key":"2444_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S8756-3282(01)00504-X","volume":"29","author":"S Christgau","year":"2001","unstructured":"Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P: Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone. 2001, 29: 209-215.","journal-title":"Bone"},{"key":"2444_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/ard.62.4.332","volume":"62","author":"U Mouritzen","year":"2003","unstructured":"Mouritzen U, Christgau S, Lehmann HJ, Tanko LB, Christiansen C: Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann Rheum Dis. 2003, 62: 332-336.","journal-title":"Ann Rheum Dis"},{"key":"2444_CR17","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1186\/ar1152","volume":"6","author":"P Hoegh-Andersen","year":"2004","unstructured":"Hoegh-Andersen P, Tanko L, Andersen T, Lundberg C, Mo J, Heegaard AM, Delaisse JM, Christgau S: Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther. 2004, 6: R169-R180.","journal-title":"Arthritis Res Ther"},{"key":"2444_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S8756-3282(01)00431-8","volume":"28","author":"P Garnero","year":"2001","unstructured":"Garnero P, Christgau S, Delmas PD: The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone. Bone. 2001, 28: 461-464.","journal-title":"Bone"},{"key":"2444_CR19","doi-asserted-by":"publisher","first-page":"R625","DOI":"10.1186\/ar1716","volume":"7","author":"TD Spector","year":"2005","unstructured":"Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, Valent DJ, Meyer JM: Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther. 2005, 7: R625-R633.","journal-title":"Arthritis Res Ther"},{"key":"2444_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/art.20930","volume":"52","author":"N Charni","year":"2005","unstructured":"Charni N, Juillet F, Garnero P: Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 2005, 52: 1081-1090.","journal-title":"Arthritis Rheum"},{"key":"2444_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.joca.2007.09.006","volume":"16","author":"AC Bay-Jensen","year":"2008","unstructured":"Bay-Jensen AC, Andersen TL, Charni-Ben Tabassi N, Kristensen PW, Kjaersgaard-Andersen P, Sandell L, Garnero P, Delaisse JM: Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage. 2008, 16: 615-623.","journal-title":"Osteoarthritis Cartilage"},{"key":"2444_CR22","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO;2-A","volume":"42","author":"T Aigner","year":"1999","unstructured":"Aigner T, Zhu Y, Chansky HH, Matsen FA, Maloney WJ, Sandell LJ: Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum. 1999, 42: 1443-1450.","journal-title":"Arthritis Rheum"},{"key":"2444_CR23","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/rheumatology\/kel409","volume":"46","author":"M Sharif","year":"2007","unstructured":"Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P: A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis \u2013 association with disease progression. Rheumatology (Oxford). 2007, 46: 938-943.","journal-title":"Rheumatology (Oxford)"},{"key":"2444_CR24","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.10576","volume":"46","author":"P Garnero","year":"2002","unstructured":"Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD: Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum. 2002, 46: 2613-2624.","journal-title":"Arthritis Rheum"},{"key":"2444_CR25","doi-asserted-by":"crossref","first-page":"10334","DOI":"10.1016\/S0021-9258(18)86950-2","volume":"265","author":"MC Ryan","year":"1990","unstructured":"Ryan MC, Sandell LJ: Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem. 1990, 265: 10334-10339.","journal-title":"J Biol Chem"},{"key":"2444_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.WCB.0000121484.18437.98","volume":"11","author":"S Christgau","year":"2004","unstructured":"Christgau S, Tanko LB, Cloos PAC, Mouritzen U, Christensen C, Delaisse JM, Hoegh-Andersen P: Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause. 2004, 11: 508-518.","journal-title":"Menopause"},{"key":"2444_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0009-9120(79)90032-8","volume":"12","author":"FW Spierto","year":"1979","unstructured":"Spierto FW, MacNeil ML, Burtis CA: The effect of temperature and wavelength on the measurement of creatinine with the Jaffe procedure. Clin Biochem. 1979, 12: 18-21.","journal-title":"Clin Biochem"},{"key":"2444_CR28","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1177\/002215549704501104","volume":"45","author":"A Oganesian","year":"1997","unstructured":"Oganesian A, Zhu Y, Sandell LJ: Type IIA procollagen amino propeptide is localized in human embryonic tissues. J Histochem Cytochem. 1997, 45: 1469-1480.","journal-title":"J Histochem Cytochem"},{"key":"2444_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF00489922","volume":"89","author":"KL Camplejohn","year":"1988","unstructured":"Camplejohn KL, Allard SA: Limitations of safranin 'O' staining in proteoglycan-depleted cartilage demonstrated with monoclonal antibodies. Histochemistry. 1988, 89: 185-188.","journal-title":"Histochemistry"},{"key":"2444_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.bone.2004.06.019","volume":"35","author":"TL Andersen","year":"2004","unstructured":"Andersen TL, del Carmen OM, Kirkegaard T, Lenhard T, Foged NT, Delaisse JM: A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. Bone. 2004, 35: 1107-1119.","journal-title":"Bone"},{"key":"2444_CR31","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/art.22009","volume":"54","author":"S Oestergaard","year":"2006","unstructured":"Oestergaard S, Sondergaard BC, Hoegh-Andersen P, Henriksen K, Qvist P, Christiansen C, Tanko LB, Karsdal MA: Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: Implications of the time of initiation. Arthritis Rheum. 2006, 54: 2441-2451.","journal-title":"Arthritis Rheum"},{"key":"2444_CR32","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.bone.2004.07.017","volume":"35","author":"P Ravn","year":"2004","unstructured":"Ravn P, Warming L, Christgau S, Christiansen C: The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy. Bone. 2004, 35: 1216-1221.","journal-title":"Bone"},{"key":"2444_CR33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/gme.0b013e318054e2ce","volume":"15","author":"T Kojima","year":"2008","unstructured":"Kojima T, Kojima M, Noda K, Ishiguro N, Poole AR: Influences of menopause, aging, and gender on the cleavage of type II collagen in cartilage in relationship to bone turnover. Menopause. 2008, 15: 133-137.","journal-title":"Menopause"},{"key":"2444_CR34","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.joca.2008.02.008","volume":"16","author":"N Charni","year":"2008","unstructured":"Charni N, Desmarais S, Bay-Jensen A, Delaisse JM, Percival MD, Garnero P: The type II collagen fragments Helix-II and CTX-II reveal distinct enzymatic pathways of cartilage collagen degradation. Osteoarthr Cartil. 2008, 16: 1183-1191.","journal-title":"Osteoarthr Cartil"},{"key":"2444_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00296-003-0312-5","volume":"23","author":"YJ Lee","year":"2003","unstructured":"Lee YJ, Lee EB, Kwon YE, Lee JJ, Cho WS, Kim HA, Song YW: Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 amd tissue inhibitor of metalloproteinase-1 in osteoarthritis chondrocytes. Rheumatology International. 2003, 23: 282-288.","journal-title":"Rheumatology International"},{"key":"2444_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1139\/O07-016","volume":"85","author":"T Lu","year":"2007","unstructured":"Lu T, Achari Y, Rattner JB, Hart DA: Evidence that estrogen receptor beta enhances MMP-13 promoter activity in HIG-82 cells and that this enhancement can be influenced by ligands and involves specific promoter sites 2. Biochem Cell Biol. 2007, 85: 326-336.","journal-title":"Biochem Cell Biol"},{"key":"2444_CR37","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1210\/endo.142.12.8533","volume":"142","author":"V Parikka","year":"2001","unstructured":"Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Harkonen P, Vaananen HK: Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology. 2001, 142: 5371-5378.","journal-title":"Endocrinology"},{"key":"2444_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1006\/bbrc.1996.0947","volume":"223","author":"H Mano","year":"1996","unstructured":"Mano H, Yuasa T, Kameda T, Miyazawa K, Nakamaru Y, Shiokawa M, Mori Y, Yamada T, Miyata K, Shindo H, Azuma H, Hakeda Y, Kumegawa M: Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun. 1996, 223: 637-642.","journal-title":"Biochem Biophys Res Commun"},{"key":"2444_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bone.2005.04.032","volume":"37","author":"YZ Bagger","year":"2005","unstructured":"Bagger YZ, Tanko LB, Alexandersen P, Karsdal MA, Olson M, Mindeholm L, Azria M, Christiansen C: Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone. 2005, 37: 425-430.","journal-title":"Bone"},{"key":"2444_CR40","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/art.22083","volume":"54","author":"S Oestergaard","year":"2006","unstructured":"Oestergaard S, Chouinard L, Doyle N, Smith SY, Tanko LB, Qvist P: Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis. Arthritis Rheum. 2006, 54: 2886-2890.","journal-title":"Arthritis Rheum"},{"key":"2444_CR41","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/art.20493","volume":"50","author":"P Garnero","year":"2004","unstructured":"Garnero P, Sornay-Rendu E, Arlot M, Christiansen C, Delmas PD: Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study. Arthritis Rheum. 2004, 50: 3137-3144.","journal-title":"Arthritis Rheum"},{"key":"2444_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/13697130701457729","volume":"10","author":"M Gambacciani","year":"2007","unstructured":"Gambacciani M, Pepe A, Cappagli B, Palmieri E, Genazzani AR: The relative contributions of menopause and aging to postmenopausal reduction in intervertebral disk height. Climacteric. 2007, 10: 298-305.","journal-title":"Climacteric"},{"key":"2444_CR43","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8","volume":"43","author":"L Dahlberg","year":"2000","unstructured":"Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR: Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum. 2000, 43: 673-682.","journal-title":"Arthritis Rheum"},{"key":"2444_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","volume":"86","author":"ER Simpson","year":"2003","unstructured":"Simpson ER: Sources of estrogen and their importance*1. J Steroid Biochem Mol Biol. 2003, 86: 225-230.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2444_CR45","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1210\/en.2006-0334","volume":"147","author":"F Grassi","year":"2006","unstructured":"Grassi F, Fan X, Rahnert J, Weitzmann MN, Pacifici R, Nanes MS, Rubin J: Bone re\/modeling is more dynamic in the endothelial nitric oxide synthase(-\/-) mouse. Endocrinology. 2006, 147: 4392-4399.","journal-title":"Endocrinology"},{"key":"2444_CR46","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1161\/01.ATV.19.12.2871","volume":"19","author":"MV Gurjar","year":"1999","unstructured":"Gurjar MV, Sharma RV, Bhalla RC: eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol. 1999, 19: 2871-2877.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2596\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:36:55Z","timestamp":1728383815000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,2]]}},"alternative-id":["2444"],"URL":"https:\/\/doi.org\/10.1186\/ar2596","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,20]]},"assertion":[{"value":"24 June 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R9"}}